Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients

Abstract Objective The purpose of this study was to examine the levels of cerebrospinal fluid (CSF) apolipoprotein E (apoE) species in Alzheimer’s disease (AD) patients. Methods We analyzed two CSF cohorts of AD and control individuals expressing different APOE genotypes. Moreover, CSF samples from...

Full description

Bibliographic Details
Main Authors: Matthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, Elena Camporesi, Gunnar Brinkmalm, Daniel Alcolea, Juan Fortea, Alberto Lleó, Guadalupe Soria, Fernando Aguado, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
apoE
Biomarker
Aberrant complexes
Cerebrospinal fluid
Glycoform imbalance
Online Access:https://doi.org/10.1186/s13195-022-01108-2

Internet

https://doi.org/10.1186/s13195-022-01108-2

Similar Items